Madrigal Pharmaceuticals logo

Senior Director, Global Safety Physician

Madrigal Pharmaceuticals

Waltham, MA; Conshohocken, PAOnsitePosted 1 day ago$318,104 - $388,792 per year
Full TimeDirector & AbovePharmacovigilance / Drug SafetyPharmaceutical
Original posting ↗

Summary

The Senior Director, Global Safety Physician provides medical safety leadership for assigned investigational and marketed products, with accountability for medically sound safety assessments, ongoing benefit-risk evaluation, and timely recommendations to protect patients. The role partners closely with safety scientists, Clinical Development, Regulatory Affairs, Biostatistics, and Clinical Operations, contributing to regulatory submissions and safety governance.

Job description

Medical Oversight & Signal Management

  • Provide medical oversight of assigned products, including review and interpretation of safety data from clinical trials, post-marketing sources, and scientific literature.
  • Provide medical leadership in the evaluation and management of safety signals, working with safety scientists responsible for routine surveillance and process execution.
  • Assess emerging safety findings, determine their medical significance, and recommend appropriate risk mitigation and regulatory actions.
  • Lead medical benefit-risk assessments for assigned products, integrating clinical, nonclinical, and post-marketing evidence to inform development and lifecycle decisions.
  • Serve as a key member or designated chair of Safety Review Teams (SRTs), presenting evidence-based recommendations and escalating significant issues through established governance.

Regulatory & Scientific Contributions

  • Author or medically review safety content in key regulatory documents, including DSURs, PBRERs, RMPs, IBs, clinical study reports, and regulatory submissions.
  • Provide medical safety expertise for regulatory filings and interactions, including INDs, NDAs/BLAs, marketing authorization applications, and responses to health authority inquiries.
  • Contribute to product safety information, labeling, and risk management strategies throughout the product lifecycle.
  • Support inspections and audits as the medical safety subject-matter expert, ensuring assessments, decisions, and supporting documentation are scientifically defensible and inspection-ready.
  • Maintain awareness of emerging scientific evidence, therapeutic developments, and regulatory expectations relevant to assigned products.

Cross-functional Collaboration

  • Provide proactive medical safety input into clinical development plans, study protocols, safety monitoring, stopping rules, and risk mitigation strategies.
  • Develop and execute medical safety strategy for assigned products and studies, partnering with Clinical Development, Biostatistics, Regulatory Affairs, and other stakeholders.
  • Evaluate emerging safety data to inform clinical development decisions and recommend changes to monitoring or risk management as appropriate.
  • Serve as an escalation point for complex or clinically significant safety cases from internal and external medical review teams; collaborate with PV Operations and safety scientists to support consistent evaluations.
  • Provide medical safety expertise to cross-functional governance committees and collaborate with Medical Affairs on relevant post-marketing safety activities.
  • Communicate safety findings, benefit-risk considerations, and actionable recommendations clearly to cross-functional teams, safety governance forums, and senior leadership.
  • Exercise independent medical judgment, constructively challenge assumptions, and influence decisions through balanced scientific reasoning.
  • Identify and escalate significant safety concerns promptly, providing clear, actionable recommendations.
  • Foster collaboration, scientific rigor, accountability, and continuous improvement across safety activities.
  • Mentor safety physicians and scientific colleagues, sharing medical expertise and supporting their development; manage direct reports where assigned.

Requirements

  • MD or equivalent medical degree
  • Completion of relevant clinical training
  • Substantial experience in clinical safety, pharmacovigilance, or pharmaceutical clinical development
  • Approximately 15 or more years of relevant combined clinical and pharmaceutical industry experience
  • Meaningful experience in drug safety or pharmacovigilance
  • Demonstrated medical safety leadership on clinical development programs
  • Experience with post-marketing safety assessment
  • Strong understanding of global safety regulations and guidelines including GCP, ICH E2 guidelines, EU GVP, and FDA requirements
  • Expertise in safety signal evaluation, medical causality assessment, benefit-risk assessment, and risk mitigation
  • Experience preparing or medically reviewing safety content for regulatory submissions
  • Experience participating in safety governance and health authority interactions
  • Working knowledge of safety databases (e.g., Argus, ArisGlobal), MedDRA, and safety surveillance methodologies
  • Demonstrated ability to work effectively in global, matrixed organizations and influence cross-functional decisions
  • Strong clinical reasoning, analytical judgment, and problem-solving skills
  • Excellent written and verbal communication skills

Benefits

  • Flexible PTO
  • Medical, Dental & Vision
  • Life & Disability Insurance
  • 401(k) Matching
  • Equity
  • Mental Health Benefits
  • Employee Assistance Program
  • Supplemental Life Insurance
  • Legal Services

Company overview

Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. The company's lead product, Rezdiffra (resmetirom), is a once-daily, oral thyroid hormone receptor (THR)-β selective agonist that targets key underlying causes of MASH in the liver. Rezdiffra received FDA approval in 2024 as the first treatment for MASH with moderate to advanced liver fibrosis, representing a significant breakthrough in hepatology. Headquartered in Conshohocken, Pennsylvania, Madrigal is publicly traded on NASDAQ under the symbol MDGL. The company continues to advance its clinical development programs, including ongoing Phase 3 trials evaluating Rezdiffra for the treatment of compensated MASH cirrhosis. Madrigal's innovative approach addresses a critical unmet medical need in liver disease therapeutics.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.